Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Dansk Innovation

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 10
Average round size
info
The average size of a deal this fund participated in
$16M
Portfolio companies 2
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.80
Exits 1
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Wellness
  • Consulting
  • Food and Beverage
Summary

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Dansk Innovation, startups are often financed by Novartis Venture Fund, Yamanouchi Venture Capital, Index Ventures. The meaningful sponsors for the fund in investment in the same round are Novartis Venture Fund, Index Ventures, Aravis Ventures. In the next rounds fund is usually obtained by Novartis Venture Fund, Johnson & Johnson Development Corporation, Index Ventures.

The top activity for fund was in 2006. The fund is generally included in less than 2 deals every year. The higher amount of exits for fund were in 2009. Opposing the other organizations, this Dansk Innovation works on 18 percentage points less the average amount of lead investments. The common things for fund are deals in the range of 10 - 50 millions dollars.

Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Evolva, 7TM Pharma. Among the most successful fund investment fields, there are Wellness, Therapeutics. The fund has no specific favorite in a number of founders of portfolio startups.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Dansk Innovation:
Typical Co-investors
Dansk Innovation is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Dansk Innovation:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
3sbio China, Liaoning, Shenyang
Brazos Private Equity Partners Dallas, Texas, United States
Capital for Enterprise England, Sheffield, United Kingdom
Claridge Israel Herzliya, Israel, Tel Aviv
JD MRO Beijing, Beijing, China
L & T Property Investments Allen Park, Michigan, United States
L Squared Capital Partners Chicago, Illinois, United States
North Run Capital Partners Boston, Massachusetts, United States
Qianfeng Capital -
Riverside Medical Group -
Selous Venture Society Nashville, Tennessee, United States
SFund International China, Hong Kong, Hong Kong Island
Structural Capital California, Menlo Park, United States
Swiftsure Capital Seattle, United States, Washington
The Orogen Group New York, New York, United States
The Renewable Energy Corporation Central, Central Region, Singapore
U.K. Steel Enterprise England, Sheffield, United Kingdom
Wider Wake Networks New York, New York, United States
Zhonglian Baiwen Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Evolva

Biotechnology
Consulting
Food and Beverage
Health Care
Wellness
$17M11 Dec 2009 Aargau, Switzerland

Evolva

Biotechnology
Consulting
Food and Beverage
Health Care
Wellness
$30M22 Oct 2009 Aargau, Switzerland

Evolva

Biotechnology
Consulting
Food and Beverage
Health Care
Wellness
$10M01 Dec 2006 Aargau, Switzerland

7TM Pharma

Biotechnology
Health Care
Therapeutics
$22M31 Mar 2006 Denmark, " Denmark"}

Evolva

Biotechnology
Consulting
Food and Beverage
Health Care
Wellness
$2M21 Mar 2005 Aargau, Switzerland

7TM Pharma

Biotechnology
Health Care
Therapeutics
$7M28 Oct 2004 Denmark, Capital Region of Denmark, Denmark

Evolva

Biotechnology
Consulting
Food and Beverage
Health Care
Wellness
$14M16 Aug 2004 Aargau, Switzerland

7TM Pharma

Biotechnology
Health Care
Therapeutics
$15M27 Sep 2001 Denmark, " Denmark"}

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Dansk Innovation?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 10
Average round size 16M
Peak activity year 2009
Lead investments 0
Follow on index 0.80
Exits 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Evolva

Biotechnology
Consulting
Food and Beverage
Health Care
Wellness
$17M11 Dec 2009 Aargau, Switzerland

Evolva

Biotechnology
Consulting
Food and Beverage
Health Care
Wellness
$30M22 Oct 2009 Aargau, Switzerland

Evolva

Biotechnology
Consulting
Food and Beverage
Health Care
Wellness
$10M01 Dec 2006 Aargau, Switzerland

7TM Pharma

Biotechnology
Health Care
Therapeutics
$22M31 Mar 2006 Denmark, " Denmark"}

Evolva

Biotechnology
Consulting
Food and Beverage
Health Care
Wellness
$2M21 Mar 2005 Aargau, Switzerland

7TM Pharma

Biotechnology
Health Care
Therapeutics
$7M28 Oct 2004 Denmark, Capital Region of Denmark, Denmark

Evolva

Biotechnology
Consulting
Food and Beverage
Health Care
Wellness
$14M16 Aug 2004 Aargau, Switzerland

7TM Pharma

Biotechnology
Health Care
Therapeutics
$15M27 Sep 2001 Denmark, " Denmark"}
Crunchbase icon

Content report

The following text will be sent to our editors: